Tag: neuroendocrine tumor

Neuroendocrine Cancer Survivor Featured on Discovery Fit & Health TV Show

THIS JUST IN:  Tannis Brown, a pheochromocytoma patient and Vice President of the Pheo Para Troopers, will be featured on the Discovery Fit & Health Network on Monday, July 9 in a program titled Diagnosis: Dead or Alive.* The 60 minute show will focus…

Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients

The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread  (metastasized) to …

Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients

The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread  (metastasized) to …

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

Clinical Trial Recruiting Neuroendocrine Tumor Patients with Pheochromocytoma or Paraganglioma

Neuroendocrine tumor patients with malignant pheochromocytoma or paraganglioma are being sought for a multi-center clinical trial conducted by Molecular Insight Pharmaceuticals, Inc. In the New York area, one of the clinical trial sites is the Mount…

Carcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment

Determining Molecular Signature:  A Guide for Targeted Therapy of Neuroendocrine Tumors

Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis.  This is the cutting-edge…

Worldwide Neuroendocrine Tumor (NET) Cancer Awareness Day: November 10, 2010

An extraordinary, first of its kind event is planned for November 10, 2010: Worldwide NET (neuroendocrine tumor) Cancer Awareness Day.  Leaders of carcinoid/NET patient support and advocacy groups from throughout the world have been brought together…

Carcinoid Cancer Foundation Thanks Silja Chouquet

During a recent meeting in Berlin of the international Steering Committee for Worldwide NET Cancer Awareness Day (WNCAD) on November 10, 2010, Grace Goldstein of the Carcinoid Cancer Foundation had the opportunity to hear a fascinating presentation…

More Information from “The Insurance Warrior” Now on Carcinoid Cancer Foundation Website

Insurance coverage for medical treatments and prescription drugs is a critical issue for carcinoid cancer and neuroendocrine tumor patients.  The Carcinoid Cancer Foundation is delighted to partner with Laurie Todd, “The Insurance Warrior,” to …

Carcinoid Cancer Foundation Partners with “The Insurance Warrior”

Panic — it’s the feeling in the pit of your stomach upon learning that your insurance company has denied coverage for your medication or treatment.  Laurie Todd, a survivor of late-stage appendix cancer, has gained a reputation as “The Insurance…